Articles related to Cardiology

Moderate caffeine intake (200-300 mg per day) was associated with a 40.7% lower risk of new-onset cardiometabolic multimorbidity compared to non-consumers or those consuming less than 100 mg daily.

A recent randomized controlled trial found that ertugliflozin treatment was associated with a significant reduction in the yearly rate of sustained ventricular arrhythmias (3.5 vs 13.3 events) compared to placebo in patients with heart failure and implantable cardioverter-defibrillators.

Bempedoic acid reduced major adverse cardiovascular events by 13% compared to placebo in statin-intolerant patients, with efficacy comparable to statins when normalized for LDL-C reduction.

The 2024 guideline introduces a more nuanced approach to preoperative stress testing and anticoagulation management, potentially reducing unnecessary testing and complications.

Recent evidence suggests that limiting foods high in saturated and trans fats may be more beneficial for cholesterol management than focusing solely on dietary cholesterol intake.

The ABYSS trial questions the safety of interrupting long-term beta-blocker treatment in patients with a history of uncomplicated myocardial infarction, finding that discontinuation was not noninferior to continuation.